期刊文献+

电视胸腔镜胸膜固定术治疗恶性胸腔积液的临床疗效及影响因素 被引量:13

Clinical efficacy and influencing factors of malignant pleural effusion paitents treated with VATS pleurodesed
下载PDF
导出
摘要 目的:探讨电视胸腔镜胸膜固定术治疗恶性胸腔积液的临床效果,总结影响恶性胸腔积液的相关因素。方法:回顾性分析2011年1月至2013年1月87例恶性胸腔积液患者的临床资料。全部采用电视胸腔镜胸膜固定术治疗,观察其术后的临床效果,并分析影响中位生存时间的因素。结果:电视胸腔镜胸膜固定术治疗恶性胸腔积液的总有效率为63.2%。不良反应总发生率为9.1%。Karnfsky生活质量稳定以上的占97.7%。胸膜肥厚和包裹积液的总发生率为19.5%。肿瘤类型、CEA、LDH、蛋白质含量、沙培林灌注、胸水Glu水平均是电视胸腔镜胸膜固定术治疗恶性胸腔积液的主要影响因素(P<0.05)。结论:电视胸腔镜胸膜固定术治疗恶性胸腔积液临床效果确切,而肿瘤类型、CEA、LDH、蛋白质含量、沙培林灌注、胸水Glu水平是影响预后的相关因素。 Objective:To study the clinical efficacy and influencing factors of malignant pleural effusion paitents tredted with VATS pleurodesed. Methods:All 87 paitents with VATS pleurodesed from January 2011 to January 2013. Clinical data were analysed. They were treated by adopt video - assisted thoracoscope pleurodesis. Results:Clin-ical effect was 63. 2% . Total incidence of adverse reaction was 9. 1% . Karnfsky life quality stability was 97. 7% . Pleural effusion hypertrophy and package the total incidence rate was 19. 5% . Tumor types,CEA,LDH,protein con-tent,ShaPeiLin perfusion,chest water Glu levels were video - assisted thoracoscope pleurodesis treatment of malignant pleural effusion main influenced factors(P 〈 0. 05). Conclusion:Video - assisted thoracoscope pleurodesis in the treatment of malignant pleural effusion is effective,and the tumor types,CEA,LDH,protein content,ShaPeiLin perfu-sion,chest water Glu levels are related factors affecting the prognosis.
出处 《现代肿瘤医学》 CAS 2015年第19期2758-2760,共3页 Journal of Modern Oncology
基金 湖北省自然科学基金面上项目(编号:2012FFB02324)
关键词 恶性胸腔积液 胸腔镜胸膜固定术 临床效果 影响因素 malignant pleural effusion thoracoscope pleurodesis clinical effect influence factors
  • 相关文献

参考文献9

二级参考文献61

共引文献47

同被引文献99

  • 1王宏虹,刘华钢,刘丽敏.β-榄香烯抗肿瘤作用机制研究概况[J].药物评价研究,2009,32(2):140-143. 被引量:21
  • 2花文峰,蔡绍晖.β-榄香烯抗肿瘤作用的基础与临床研究[J].中药材,2006,29(1):93-97. 被引量:86
  • 3李志杰,张媛.榄香烯联合化疗治疗肺癌合并恶性胸腔积液疗效观察[J].中国误诊学杂志,2006,6(20):3932-3933. 被引量:6
  • 4师国强.榄香烯乳胸腔内注射治疗恶性胸腔积液的疗效观察[J].实用诊断与治疗杂志,2007,21(5):373-374. 被引量:22
  • 5Jaffe ES,Harris NL,Stain H,et al.World Health Organization classification of tumours.Pathology and genet ics of tumours of haematopoietic and lymphoid tissues[M].Lyon:IARC Press,2001:179-180.
  • 6Chen YB,Rahemtullah A,Hochberg E.Primary effusion lymphoma[J].Oncologist,2007,12(5):569-576.
  • 7周晓鸽,陈辉树,主译.《WHO世界卫生组织肿瘤分类及诊断标准系列》造血与淋巴组织肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006:7.
  • 8Dongen VJ,Langerak AW,Bruggemann M,et al.Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations:Report of the BIOMED-2 Concerted Action BMH4-CT98-3936[J].Leukemia,2003,17(12):2257-2317.
  • 9Navarro WH,Kaplan LD.AIDS related lymphoid proliferative disease[J].Blood,2006,107(1):13-20.
  • 10Little RF,Gutierrez M,Jaffe ES et al.HIV-associated non-Hodgkin lymphoma:Incidence,presentation,and prognosis[J].JAMA,2001,285(14):1880-1885.

引证文献13

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部